Diaceutics and Labroots Announce "Precision Medicine in
Oncology " Virtual Event:
A
Cutting-Edge Exploration of Cancer Diagnostics &
Treatment
Belfast and London, 13 June 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions
provider to the pharma and biotech industry, is pleased
to announce its upcoming virtual event to be
hosted in collaboration with Labroots - "Precision
medicine in oncology," on 19 June,
2024.
This groundbreaking event will take
attendees to the forefront of cancer testing & treatment
through a series of eight live webinars, culminating in a full day
of immersive, true-to-life virtual experiences. The virtual
sessions will cover topics that are revolutionising cancer analysis
& diagnostics, including immunotherapy; liquid biopsy;
pre-analytical phase; NGS; Cytology and CE marked
Invitro-Diagnostic Regulations.
Event Speakers will include:
|
·
|
Prof. Dr. Klaus Pantel, Director of the Institute of Tumor
Biology at the University Medical Center Hamburg-Eppendorf,
Germany: Presenting "Implementation
of Liquid Biopsy in Precision Oncology," Prof. Pantel, a pioneer in
cancer cell research, will provide a comprehensive introduction to
and review of the evolution of precision medicine, focusing on the
implementation of liquid biopsy in precision oncology.
|
|
·
|
Dr.
Bob Holt, Senior Precision Medicine Strategy Advisor at
Diaceutics: Presenting "MRD in Solid
Tumor and Hematological Indications: Today and Tomorrow," Dr. Holt
will analyse the clinical utility and technology behind Minimal
Residual Disease (MRD). This session will be followed by Prof.
Maria Teresa Voso, Prof. of Hematology at Tor Vergata University,
who will discuss the pros and cons of MRD in AML and engage in a
discussion with Dr. Holt and all attendees.
|
|
·
|
Prof. Paul Hoffman, Professor of Pathology at the University
Côte d'Azur, Nice, France:
Presenting on "New challenges in early-stage cancer". This
presentation will explore early detection and management of
early-stage cancers.
|
|
·
|
Dr.
Clare Turnbull, PhD FRCP FRCPath FFPH, Professor of Translational
Cancer Genetics in the Division of Genetics & Epidemiology at
the Institute of Cancer Research and NHS Honorary Consultant in
Clinical Cancer Genetics, London and
Dr Nicola Normanno, MD, Director
of Translational Research,
National Cancer Institute, Pascale Foundation, Italy:
Presenting "The Role of Comprehensive Genomic Profiling in
Precision Oncology," this session promises insights into the
implications of large NGS panels, co-mutations, and the
introduction of patients harboring germline variants.
|
|
·
|
Prof. Sophie Prévot, Pathologist at the Bicêtre Hospital,
Paris: Presenting "Integrating AI in
Pathology: Advancing Diagnoses & Workflow Efficiency," this
presentation will explore how AI tools can support doctors in
making accurate diagnoses and enhancing workflow
efficiency.
|
Ryan Keeling, CEO of Diaceutics,
commented, "Our commitment is to transform the landscape
of cancer treatment through precision medicine. This event provides
an unparalleled platform for experts to share innovative practices
and insights that will shape the future of oncology diagnostics. We
are pleased to host this gathering of thought leaders and advance
our mission of ensuring every patient receives the right treatment
at the right time."
The event is tailored for laboratory
professionals, pathologists, and anyone involved in oncology
diagnostics and treatment. In addition to the expert presentations,
attendees can participate in interactive sessions, visit the poster
hall, and engage in real-time Q&A sessions with expert
speakers.
For further information about the
event and to register for free,
click here.
About
Diaceutics
At Diaceutics we believe that every
patient should get the opportunity to receive the right test and
the right therapy to positively impact their disease
outcome.
We provide the world's leading
pharma and biotech companies with an end-to-end commercialisation
solution for precision medicines through data analytics, scientific
and advisory services enabled by our platform DXRX - The
Diagnostics Network®.
About Labroots
Labroots is
the leading scientific social networking website, and primary
source for scientific trending news and premier educational virtual
events and webinars and more. Contributing to the advancement of
science through content sharing capabilities, Labroots is a
powerful advocate in amplifying global networks and communities.
Founded in 2008, Labroots emphasises digital innovation in
scientific collaboration and learning. Offering more than articles
and webcasts that go beyond the mundane and explore the latest
discoveries in the world of science, Labroots users can stay atop
their field by gaining continuing education credits from a wide
range of topics through their participation in the webinars and
virtual events.
Enquiries:
|
Diaceutics PLC
|
|
|
Ryan Keeling, Chief Executive
Officer
Nick Roberts, Chief Financial
Officer
|
Tel: +44 (0)28 9040 6500
investorrelations@diaceutics.com
|
|
Stifel Nicolaus Europe Limited (Nomad &
Broker)
|
Tel: +44 (0)20 7710
7600
|
|
Ben Maddison
|
|
|
Nick Harland
|
|
|
Kate Hanshaw
|
|
|
|
|
|
Alma Strategic Communications
|
Tel: +44(0)20 3405
0205
|
|
Caroline Forde
Kinvara Verdon
Kieran Breheny
|
diaceutics@almastrategic.com
|
|
|
|
